Investing.com - P3 Health Partners (NASDAQ: PIII) reported third quarter EPS of $-0.12, $0.06 better than the analyst estimate of $-0.18. Revenue for the quarter came in at $288.35M versus the consensus estimate of $293.42M.
Guidance
P3 Health Partners sees FY 2023 revenue of $1.20B-$1.25B versus the analyst consensus of $1.24B.
P3 Health Partners's stock price closed at $1.31. It is down -33.84% in the last 3 months and down -70.09% in the last 12 months.
P3 Health Partners saw positive EPS revisions and negative EPS revisions in the last 90 days. See P3 Health Partners's stock price’s past reactions to earnings here.
According to InvestingPro, P3 Health Partners's Financial Health score is "fair performance".
Check out P3 Health Partners's recent earnings performance, and P3 Health Partners's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar